GE HealthCare Technologies Inc. (GEHC)
Automate Your Wheel Strategy on GEHC
With Tiblio's Option Bot, you can configure your own wheel strategy including GEHC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol GEHC
- Rev/Share 44.3969
- Book/Share 22.4123
- PB 3.7824
- Debt/Equity 1.0752
- CurrentRatio 1.1807
- ROIC 0.0799
- MktCap 37860192842.0
- FreeCF/Share 3.0702
- PFCF 27.043
- PE 17.0568
- Debt/Assets 0.2974
- DivYield 0.0017
- ROE 0.2374
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 4
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | GEHC | Barclays | -- | Equal Weight | -- | $86 | Oct. 13, 2025 |
| Downgrade | GEHC | Citigroup | Buy | Neutral | -- | $83 | Oct. 7, 2025 |
| Upgrade | GEHC | UBS | Sell | Neutral | -- | $73 | May 5, 2025 |
| Upgrade | GEHC | Goldman | Neutral | Buy | $85 | $100 | March 11, 2025 |
| Upgrade | GEHC | Jefferies | Hold | Buy | $95 | $103 | Jan. 8, 2025 |
| Downgrade | GEHC | UBS | Neutral | Sell | $84 | $74 | Sept. 26, 2024 |
| Upgrade | GEHC | BTIG Research | Neutral | Buy | -- | $100 | Sept. 18, 2024 |
| Initiation | GEHC | JP Morgan | -- | Neutral | -- | $90 | Sept. 9, 2024 |
News
GE HealthCare expands invasive cardiology solutions portfolio with AltiX AI.i for elevated experience in catheterization lab and electrophysiology procedures
Published: March 17, 2025 by: Business Wire
Sentiment: Neutral
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the launch of the AltiX AI.i edition of Mac-Lab™, CardioLab™ and ComboLab™. The AltiX AI.i editions are designed to improve the user experience, elevating workflow in the cardiac catheterization (cath) lab and supporting even the most complex electrophysiology (EP) procedures. These latest editions offer new features that can streamline workflow and enhance interoperability, while upholding strong cybersecurity standards. Ca.
Read More
NVIDIA's AI Speeds Up MedTech's Digital Boom: 3 Stocks in Focus
Published: March 12, 2025 by: Zacks Investment Research
Sentiment: Positive
RMD, GEHC and MDT are expected to thrive as NVIDIA and other AI leaders' MedTech ventures accelerate digital adoption within the space.
Read More
Goldman Sachs Gains Confidence In Market Rebound, Upgrades GE Healthcare Amid China Recovery Hopes
Published: March 11, 2025 by: Benzinga
Sentiment: Positive
Last week, U.S. President Donald Trump vowed to impose a 25% tariff on imported goods from Mexico and Canada and to double tariffs on those from China to 20%.
Read More
GEHC Stock May Gain as Genesis Portfolio Expands Cloud Offerings
Published: March 11, 2025 by: Zacks Investment Research
Sentiment: Positive
GE HealthCare unveils Genesis, a cloud-based imaging portfolio designed to enhance healthcare efficiency, streamline data access, and drive digital transformation.
Read More
GE HealthCare Technologies (GEHC) is a Top-Ranked Value Stock: Should You Buy?
Published: February 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
GE HealthCare Tops Q4 EPS Forecasts
Published: February 13, 2025 by: The Motley Fool
Sentiment: Positive
Medical technology and pharmaceutical diagnostics specialist GE HealthCare Technologies (GEHC -1.30%) reported mixed financial results for the fourth quarter of 2024 on Thursday, Feb. 13. Adjusted earnings per share (EPS) of $1.45 were a significant beat over the anticipated $1.27.
Read More
GE HealthCare Technologies (GEHC) Surpasses Q4 Earnings Estimates
Published: February 13, 2025 by: Zacks Investment Research
Sentiment: Positive
GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.45 per share, beating the Zacks Consensus Estimate of $1.26 per share. This compares to earnings of $1.18 per share a year ago.
Read More
GE HealthCare forecasts upbeat 2025 profit on steady medical device demand
Published: February 13, 2025 by: Reuters
Sentiment: Positive
GE HealthCare Technologies on Thursday forecast annual profit above Wall Street estimates, counting on strong demand for its medical devices in markets such as the U.S. to offset weakness in China.
Read More
GEHC Q4 Earnings: Will Robust Procedures Help Offset Chinese Weakness?
Published: February 10, 2025 by: Zacks Investment Research
Sentiment: Positive
GEHC's fourth-quarter results are likely to reflect mixed segmental performance in imaging, advanced visualization solutions and patient care. Pharma is likely to have been the key driver.
Read More
About GE HealthCare Technologies Inc. (GEHC)
- IPO Date 2022-12-15
- Website https://www.gehealthcare.com
- Industry Medical - Healthcare Information Services
- CEO Peter J. Arduini
- Employees 53000